|
|
|
|
LEADER |
00000nam a22000004a 4500 |
001 |
3855925 |
003 |
ICU |
005 |
20030528022900.0 |
008 |
990205s1999 nyua b 001 0 eng c |
010 |
|
|
|a 99019720
|
020 |
|
|
|a 1850700818
|
035 |
|
|
|a 99019720
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d NhCcYBP
|d OrLoB-B
|d OCoLC
|
042 |
|
|
|a pcc
|
050 |
|
4 |
|a RC280.U74
|b C66 1998
|
060 |
|
4 |
|a WJ 358
|b C749 1999
|
082 |
0 |
0 |
|a 616.99/46
|2 21
|
111 |
2 |
|
|a Congress on Progress and Controversies in Oncological Urology
|n (5th :
|d 1998 :
|c Rotterdam, Netherlands)
|
245 |
0 |
0 |
|a Renal, bladder and prostate cancer :
|b an update : the proceedings of the V Congress on Progress and Controversies in Oncological Urology (PACIOU V), held in Rotterdam, the Netherlands, October 1998 /
|c edited by Karl H. Kurth, Gerald H. Mickisch & Fritz H. Schröder.
|
260 |
|
|
|a New York :
|b Parthenon Pub.,
|c c1999.
|
300 |
|
|
|a xi, 290 p. :
|b ill. ;
|c 27 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g Sect. 1.
|t Renal cell carcinoma.
|g 1.
|t Molecular genetics of renal cell carcinoma /
|r E. Enquist, M. M. Walther and W. M. Linehan.
|g 2.
|t Limits of cure by surgery in renal cell carcinoma /
|r Z. Kirkali.
|g 3.
|t Organ-sparing surgery: magic bullet or tragic insanity? /
|r H. P. Van Poppel and L. V. Baert.
|g 4.
|t Transabdominal or retroperitoneal approach for tumor nephrectomy: an easy choice? /
|r D. Jacqmin.
|g 5.
|t Surgery for metastatic renal cell carcinoma: a matter of attitude? /
|r G. H. Mickisch.
|g 6.
|t Interferons in metastatic renal cell carcinoma: a tradition to be maintained? /
|r S. D. Fossa.
|g 7.
|t Interleukin-2 in renal cell carcinoma /
|r J. Atzpodien, J. Buer and S. Sel /
|r [et al.].
|g 8.
|t Gene therapeutic approaches for renal cell carcinoma: has the future arrived? /
|r J. W. Simons.
|g 9.
|t Cytotoxic T lymphocyte priming versus tolerance induction /
|r C. J. M. Melief, S. Schoenberger and R. J. Toes /
|r [et al.] --
|g Sect. 2.
|t Prostate cancer, localized disease.
|g 10.
|t Prostate cancer in Japan: what are the differences? /
|r K. Okada, Y. Suzuki and H. Tsuka /
|r [et al.].
|g 11.
|t Decreasing prostate cancer mortality in the USA. Is the value of screening already proven? /
|r P. C. Albertsen.
|g 12.
|t Update on the European Randomized Study of Screening for Prostate Cancer: light at the end of the tunnel /
|r L. J. Denis.
|g 13.
|t What is the optimal strategy for early detection of prostate cancer? /
|r J. Hugosson.
|g 14.
|t How many biopsies should be taken for proper diagnosis and grading? /
|r R. F. Hoedemaeker, A. E. Boeken Kruger and T. H. Van der Kwast.
|g 15.
|t Accuracy of grading: can it be replaced by other prognostic tissue factors? Present and future /
|r T. H. Van der Kwast and A. B. Houtsmuller.
|g 16.
|t Is cure of prostate cancer possible in those for whom it is necessary? /
|r P. T. Scardino, T. M. Wheeler and M. W. Kattan.
|g 17.
|t Can aggressive treatment be avoided in those who may not need it? /
|r M. Menon and A. Tewari.
|g 18.
|t Advances in radiotherapy of localized prostate cancer: improved effectiveness? /
|r M. K. Gospodarowicz, P. Warde and C. Catton /
|r [et al.].
|g 19.
|t Minimal invasive treatment alternatives for localized prostate cancer using thermal therapy or cryosurgery /
|r B. Djavan, C. Seitz and M. Marberger --
|g Sect. 3.
|t Prostate cancer, advanced disease.
|g 20.
|t Endocrine treatment of prostate cancer: the future after maximum androgen blockade and the role of PSA monitoring /
|r F. H. Schroder.
|g 21.
|t Antiandrogen monotherapy /
|r P. Iversen.
|g 22.
|t Quality of life in prostate cancer: preliminary results of two studies in patients with extensive disease /
|r G. van Andel and K. H. Kurth.
|g 23.
|t Intermittent endocrine therapy for prostate cancer /
|r N. Bruchovsky, L. H. Klotz and J. M. Crook /
|r [et al.].
|g 24.
|t New approaches to drug development in prostate cancer /
|r M. A. Eisenberger --
|g Sect. 4.
|t Bladder cancer.
|g 25.
|t Can intravesical chemotherapy prevent progression of superficial bladder cancer? /
|r F. M. J. Debruyne and J. A. Witjes.
|g 26.
|t Is intravesical BCG superior to chemotherapy? /
|r A. P. M. van der Meijden.
|g 27.
|t How long should adjuvant BCG be given? /
|r D. L. Lamm.
|g 28.
|t Urinary cytokines after intravesical immunotherapy: are they predictors? /
|r T. M. de Reijke, E. C. de Boer and K. H. Kurth /
|r [et al.].
|g 29.
|t Is bladder preservation possible in transitional carcinoma of T[subscript 1]G[subscript 3]? /
|r A. Brauers and G. Jakse.
|g 30.
|t Orthotopic urinary diversion in transitional cell carcinoma: are there limits? /
|r U. E. Studer and R. D. Mills.
|g 31.
|t The place for systemic treatment in invasive bladder carcinoma /
|r K. H. Kurth.
|g 32.
|t Gene therapy in metastatic transitional cell carcinoma of the bladder /
|r G. H. Mickisch.
|g 33.
|t Contemporary approaches for chemotherapy of metastatic urothelial cancer /
|r D. Raghavan.
|
650 |
|
0 |
|a Kidneys
|x Cancer
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010009509
|
650 |
|
0 |
|a Bladder
|x Cancer
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010008266
|
650 |
|
0 |
|a Prostate
|x Cancer
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010010103
|
650 |
1 |
2 |
|a Kidney Neoplasms
|v congresses.
|
650 |
2 |
2 |
|a Urinary Bladder Neoplasms.
|
650 |
2 |
2 |
|a Prostatic Neoplasms.
|
650 |
|
7 |
|a Bladder
|x Cancer.
|2 fast
|0 http://id.worldcat.org/fast/fst00834067
|
650 |
|
7 |
|a Kidneys
|x Cancer.
|2 fast
|0 http://id.worldcat.org/fast/fst00987386
|
650 |
|
7 |
|a Prostate
|x Cancer.
|2 fast
|0 http://id.worldcat.org/fast/fst01079479
|
700 |
1 |
|
|a Kurth, Karl H.
|0 http://id.loc.gov/authorities/names/n84026195
|1 http://viaf.org/viaf/30930033
|
700 |
1 |
|
|a Mickisch, G.
|
700 |
1 |
|
|a Schröder, F. H.
|0 http://id.loc.gov/authorities/names/n87812787
|1 http://viaf.org/viaf/250350047
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
035 |
|
|
|a (OCoLC)151984537
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 3899bb4d-3a6e-5abf-8734-e5ffa1a71b7c
|s 1dba3b7b-1130-5ccb-baee-e28860edb3dd
|
928 |
|
|
|t Library of Congress classification
|a RC280.U74 C66 1998
|l ASR
|c ASR-SciASR
|i 6296464
|
927 |
|
|
|t Library of Congress classification
|a RC280.U74 C66 1998
|l ASR
|c ASR-SciASR
|e BELF
|e CRERAR
|b 50772148
|i 6302197
|